Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...
As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...
The NHS could start administering a new weight-loss injection as early as March 2025, but eligible patients may have to wait ...
Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period. The ...
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it? - Fewer than 10% of patients in ...